The study drug is being developed as a potential new treatment for malaria.
Current approaches to controlling malaria are failing, because the malaria parasites have become resistant to the antimalarial drugs we have available.
Therefore, there is a need to develop and test new antimalarial drugs or combinations of drugs.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!